(a) whether National Pharmaceutical Pricing Authority (NPPA) has fixed/revised the price of
anti-diabetic drug Glipizide;
(b) if so, the details thereof;
(c) whether NPPA has received letters regarding fixation of price of said drug;
(d) if so, whether the NPPA has conducted a fresh cost-cum-Techno Economic study to revise
the price of drug;
(e) if so, the details and outcome thereof; and
(f) the action taken thereon?
MINISTER OF STATE IN THE MINISTRY OF CHEMICALS AND FERTILIZERS AND MINISTER OF STATE IN THE
MINISTRY OF PARTLIAMENTARY AFFAIRS (SHRI B.K. HANDIQUE)
(a) to (f): National Pharmaceutical Pricing Authority (NPPA) has revised the price of bulk drug
Glipizide from Rs.31584/- per kg fixed earlier vide notification dated 13.8.04 to Rs.29244/- per
kg vide S.O. 1043 (E) dated 11.7.2006 after a detailed Cost Price Study. The price of bulk drug
Glipizide has been fixed/revised as per the provisions of Drugs (Prices Control) Order, 1995
(DPCO 1995.)The bulk drug Glipizide was under litigation concerning its exclusion from First
Scheduled of DPCO 1995. The bulk drug price was fixed for the first time after vacation of stay
by the Supreme Court at Rs.31584/- per kg vide notification dated 13.8.04 based on a detailed
Cost cum Techno Economic Study conducted by NPPA.Government/NPPA has received letters concerning
fixation of the price of bulk drug Glipizide. During periodic monitoring of the market price by
NPPA, it was noticed that the price of the bulk drug Glipizide was ruling low compared to the
existing notified price. NPPA took a decision to conduct a fresh Cost cum Techno Economic Study
by calling information from all known manufacturers. Durii ` July, 2006 the price of bulk drug
was revised downward to Rs.29244/- per kg after a detailed study by NPPA. Market prices are
monitored based on the reports from journals only. Prices are fixed by NPPA based on cost
wherever a cost price study is conducted and such costs are independent of market prices.
Moreover prices may fluctuate from time to time. In the case of Glipizide, the cost was higher
than the market price. A uniform approach is followed while fixing the price of bulk drug under
the provisions of DPCO 1995.